No targets available; showing actuals against baseline.
Carbon per million dollars of revenue. The legacy industry-standard reference (CDP, MSCI). Useful for cross-sector context, but distorted by margin — high-margin firms appear artificially efficient. Read alongside the operational and asset intensities for the full picture.
OpEx (operating expenditure) is the running cost of the business — staff, services, energy, materials. This shows how carbon-intensive operations are per million dollars of spend. Removes the margin distortion that revenue-based ratios introduce.
EVIC (Enterprise Value Including Cash) is the firm's total capital footprint — equity + debt + cash + minority interest. The EU's standard intensity measure (SFDR PAI 3) — answers: how much carbon does each million of capital deployed in this business produce?
PP&E (Property, Plant & Equipment) plus leased real-estate assets is the firm's physical infrastructure on the balance sheet. This shows the carbon intensity of that physical footprint — uses Scope 1+2+3 for consistency with the other headline intensities. Surfaces stranded-asset risk for asset-heavy firms.
How the firm describes its decarbonisation approach in its own words — alongside the headline numbers above. Self-reported, page-cited.
Galderma achieved 100% renewable electricity across all four manufacturing sites in 2023 (up from 57% in 2022) and maintained this in 2024. The company commits to maintaining 100% renewable electricity in its manufacturing plants as part of its Scope 1 & 2 carbon neutrality ambition by 2030.
To achieve Scope 1 & 2 carbon neutrality in manufacturing plants by 2030, Galderma's plan includes the acquisition of high-quality carbon credits to compensate for residual emissions, alongside replacing carbon-intensive equipment (e.g., gas boilers) and maintaining 100% renewable electricity. The company does not distinguish removals from offsets explicitly.
Galderma is committed to enhancing water efficiency in manufacturing. Actions taken include reducing purge volumes and optimizing cooling processes. In 2024, water meters and sensors were installed across manufacturing plants and water withdrawal intensity decreased by more than 10% year-over-year. Target: 20% reduction by 2030 vs 2022 baseline.
Galderma is phasing specific capital expenditure to replace carbon-intensive equipment such as gas boilers across its four manufacturing plants in Alby-sur-Chéran, Baie-D'Urfé, Hortolândia and Uppsala. Individual decarbonization plans are tailored to each site's specificity and maturity.
Galderma reduced water withdrawal intensity by more than 10% year-over-year in 2024 (5.0 m3/ton bulk vs 5.6 in 2023) and reduced waste intensity by more than 10% YoY. All manufacturing plants send zero waste to landfill. Target: 20% reduction in both water and waste intensity by 2030 vs 2022 baseline.
Site-specific decarbonisation plans include phasing capital expenditure to replace carbon-intensive equipment such as gas boilers in the four manufacturing plants (Alby-sur-Chéran, Baie-D'Urfé, Hortolândia, Uppsala) to achieve Scope 1 & 2 carbon neutrality by 2030.
All four manufacturing plants send zero waste to landfill. Initiatives in 2024 included introducing recyclable pallets in the Hortolândia plant and minimizing waste rejects from packaging lines in Baie-D'Urfé. Waste intensity decreased by more than 10% year-over-year. Target: 20% reduction by 2030 vs 2022 baseline.
In 2024, Galderma launched a Sustainable Packaging Initiative to identify all potential sustainable packaging solutions across the Dermatological Skincare portfolio, prioritising by impact/feasibility and considering resource availability such as post-consumer recycled (PCR) plastic. A multi-disciplinary project team across Operations, Procurement, R&D, Commercial and ESG was assembled.
In 2024, Galderma launched a top supplier engagement program covering the top 80-90 suppliers in the most carbon-intensive procurement categories. Phase 1 focused on primary data collection including detailed life cycle assessments for specific raw materials to improve Scope 3 calculation accuracy. Phase 2 included discussions to identify mutually beneficial GHG reduction initiatives.
In 2024, Galderma launched a broad-based Sustainable Packaging Initiative to identify all potential sustainable packaging solutions across the Dermatological Skincare portfolio. It prioritizes initiatives by impact and feasibility and considers resource availability such as post-consumer recycled (PCR) plastic. A multi-disciplinary team includes Operations, Procurement, R&D, Commercial and ESG.
Galderma's Clean Beauty Charter lists ingredients to avoid/not use as part of every new Dermatological Skincare product development cycle. In 2024, the charter started including environmental assessment of ingredients (biodegradability, carbon footprint) to inform Scope 3 reduction efforts.
In 2024, Galderma launched a top supplier engagement program involving its top 80-90 suppliers in the most carbon-intensive procurement categories. Phase 1 focused on primary data collection (detailed LCAs for raw materials) to improve Scope 3 accuracy; Phase 2 explored mutually beneficial reduction initiatives. The program targets development of detailed Scope 3 targets for key material categories in 2025.
Galderma's Clean Beauty Charter governs ingredients in new Dermatological Skincare product development. In 2024, the Charter was expanded to include environmental assessment of ingredients (biodegradability and carbon footprint) to inform Scope 3 reduction efforts.
No target available for this scope.
No target available for this scope.
We haven't fully researched Galderma yet.
Request a full evidence-chained profile — we'll dig into their carbon, nature, social & water disclosure, find their facilities and sources, and email you when it's ready.
We’ll only use your email to notify you about this request.